Abbott Laboratories

NYSE:ABT Stock Report

Market Cap: US$194.1b

Abbott Laboratories Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:ABT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Sep 24SellUS$3,100John McCoyIndividual27US$114.83
07 May 24SellUS$2,428,119Lisa EarnhardtIndividual22,852US$106.25
01 Mar 24SellUS$101,081Hubert AllenIndividual853US$118.50
01 Mar 24SellUS$82,239Lisa EarnhardtIndividual694US$118.50
01 Mar 24SellUS$55,932John McCoyIndividual472US$118.50
01 Mar 24SellUS$80,106Mary MorelandIndividual676US$118.50
01 Mar 24SellUS$94,919Louis MorroneIndividual801US$118.50
01 Mar 24SellUS$114,116Daniel SalvadoriIndividual963US$118.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABT?
Owner TypeNumber of SharesOwnership Percentage
State or Government1,755,9170.101%
Individual Insiders8,079,7990.466%
General Public382,753,17422.1%
Institutions1,341,866,32377.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 47.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.68%
The Vanguard Group, Inc.
167,906,137US$18.8b0.93%0.27%
7.55%
BlackRock, Inc.
131,027,791US$14.7b-0.08%0.23%
7.08%
Capital Research and Management Company
122,789,437US$13.7b-6.58%0.63%
4.42%
State Street Global Advisors, Inc.
76,720,429US$8.6b3.12%0.31%
2.01%
Geode Capital Management, LLC
34,903,198US$3.9b1.42%0.27%
1.49%
Wellington Management Group LLP
25,810,977US$2.9b1.1%0.44%
1.29%
JP Morgan Asset Management
22,304,613US$2.5b131%0.27%
1.17%
Norges Bank Investment Management
20,356,932US$2.3b0%0.18%
1.15%
Northern Trust Global Investments
19,996,210US$2.2b-3.3%0.33%
1.02%
UBS Asset Management AG
17,674,029US$2.0b2.3%0.19%
0.89%
Wells Fargo & Company, Securities and Brokerage Investments
15,359,180US$1.7b0.28%0.51%
0.82%
Legal & General Investment Management Limited
14,258,807US$1.6b-0.62%0.28%
0.8%
Polen Capital Management, LLC
13,939,823US$1.6b-8.94%3.66%
0.78%
State Farm Insurance Companies, Asset Management Arm
13,587,118US$1.5b0%1.32%
0.77%
BNY Asset Management
13,337,378US$1.5b-4.3%0.28%
0.77%
Massachusetts Financial Services Company
13,319,347US$1.5b25.6%0.31%
0.73%
Charles Schwab Investment Management, Inc.
12,624,697US$1.4b-0.09%0.23%
0.72%
Morgan Stanley Investment Management Inc.
12,560,607US$1.4b-5.07%1.06%
0.7%
Columbia Management Investment Advisers, LLC
12,084,392US$1.4b13.2%0.29%
0.64%
Fisher Asset Management, LLC
11,102,204US$1.2b5.57%0.49%
0.64%
Morgan Stanley, Investment Banking and Brokerage Investments
11,030,440US$1.2b-5.34%0.14%
0.63%
Deutsche Asset & Wealth Management
10,982,996US$1.2b9.07%0.34%
0.63%
Eaton Vance Management
10,914,684US$1.2b2.05%0.27%
0.55%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
9,479,193US$1.1b3.39%0.25%
0.54%
Morgan Stanley Investment Management Limited
9,439,508US$1.1b-0.34%2.44%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 22:56
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abbott Laboratories is covered by 61 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David ToungArgus Research Company
Stephan GasteygerAtlantic Equities LLP
Ishan MajumdarBaptista Research